Product Characteristics And Pharmacological Profile Of Kte-X19 In Patients (Pts) With Relapsed/Refractory (R/R) Mantle Cell Lymphoma (Mcl) In The Phase Ii Registrational Zuma-2 Trial.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要